Tag:
R343
Latest Headlines
Latest Headlines
Rigel raises $130M for PhII trial of asthma drug
Pfizer's decision to cut all allergy and respiratory drug development work came as good news for Rigel Pharmaceuticals, even though it meant the end of the two developers' pact for allergic asthma
